NCT01597895

Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects

Open-Label, Randomized, Fixed-Sequence, Crossover Study to Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 14 (actual)
• Sponsor: ViiV Healthcare · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine the effect that telaprevir and boceprevir has on the pharmacokinetics of maraviroc.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Maraviroc	Maraviroc 150 mg BID x 5 days with food
DRUG	Maraviroc + Boceprevir	Maraviroc 150 mg BID + Boceprevir 800 mg TID x 10 days with food
DRUG	Maraviroc + Telaprevir	Maraviroc 150 mg BID + Telaprevir 800 mg TID x 10 days with food

Timeline

• Start date: 2012-07-01
• Primary completion: 2012-08-01
• Completion: 2012-08-01
• First posted: 2012-05-14
• Last updated: 2012-09-19

Locations

1 site across 1 country: Belgium